New guidelines on NHS management of type 2 diabetes will introduce a more personalised approach that could see expanded access to drug treatments, including GLP-1 agonist therapies. The shift from a ...
The market for initial public offerings (IPOs) looked as if it was finally gaining momentum in late March, but things quickly cooled as President Donald Trump's shifting tariff policies sparked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback